Publication:
Nesprin-1 impact on tumorigenic cell phenotypes

dc.contributor.coauthorHussain, Muhammed Sajid
dc.contributor.coauthorAsif, Maria
dc.contributor.coauthorNoegel, Angelika A.
dc.contributor.kuauthorSur, İlknur Erdem
dc.contributor.kuauthorDeğirmenci, Nareg Pınarbaşı
dc.contributor.kuauthorAksu, Ali Cenk
dc.contributor.kuprofileFaculty Member
dc.contributor.kuprofilePhD Student
dc.contributor.kuprofilePhD Student
dc.contributor.researchcenterKoç University Research Center for Translational Medicine (KUTTAM) / Koç Üniversitesi Translasyonel Tıp Araştırma Merkezi (KUTTAM)
dc.contributor.schoolcollegeinstituteSchool of Medicine
dc.contributor.schoolcollegeinstituteGraduate School of Health Sciences
dc.contributor.schoolcollegeinstituteGraduate School of Health Sciences
dc.contributor.yokidN/A
dc.contributor.yokidN/A
dc.contributor.yokidN/A
dc.date.accessioned2024-11-10T00:12:07Z
dc.date.issued2020
dc.description.abstractThe largest protein of the nuclear envelope (NE) is Nesprin-1 which forms a network along the NE interacting with actin, Emerin, Lamin, and SUN proteins. Mutations in the SYNE1 gene and reduction in Nesprin-1 protein levels have been reported to correlate with several age related diseases and cancer. In the present study, we tested whether Nesprin-1 overexpression can reverse the malignant phenotype of Huh7 cells, a human liver cancer cell line, which carries a mutation in the SYNE1 gene resulting in reduced Nesprin-1 protein levels, has altered nuclear shape, altered amounts and localization of NE components, centrosome localization and genome stability. Ectopic expression of a mini-Nesprin-1 led to an improvement of the nuclear shape, corrected the mislocalization of NE proteins, the centrosome positioning, and the alterations in the DNA damage response network. Additionally, Nesprin-1 had a profound effect on cellular senescence. These findings suggest that Nesprin-1 may be effective in tumorigenic cell phenotype correction of human liver cancer.
dc.description.indexedbyWoS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.issue2
dc.description.openaccessNO
dc.description.sponsorshipCologne Excellence Cluster on Cellular Stress Responses in AgingAssociated Diseases (CECAD) We thank to Dr. Reena Buurman for providing the THLE-2 cells, Rolf Muller for cloning, Dr. V. S. Peche for helping at various stages of this work, and Berthold Ga beta en for providing antibodies. The authors gratefully acknowledge the use of services and facilities of the Koc University Research Center for Translational Medicine (KUTTAM), funded by the Presidency of Turkey, Presidency of Strategy and Budget. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Presidency of Strategy and Budget. The work was supported by the Cologne Excellence Cluster on Cellular Stress Responses in AgingAssociated Diseases (CECAD).
dc.description.volume47
dc.identifier.doi10.1007/s11033-019-05184-w
dc.identifier.eissn1573-4978
dc.identifier.issn0301-4851
dc.identifier.scopus2-s2.0-85075122036
dc.identifier.urihttp://dx.doi.org/10.1007/s11033-019-05184-w
dc.identifier.urihttps://hdl.handle.net/20.500.14288/17586
dc.identifier.wos516538600008
dc.keywordsNuclear envelope
dc.keywordsNesprin-1
dc.keywordsGenome stability
dc.keywordsCancer
dc.keywordsCellular senescence
dc.languageEnglish
dc.publisherSpringer
dc.sourceMolecular Biology Reports
dc.subjectBiochemistry
dc.subjectMolecular biology
dc.titleNesprin-1 impact on tumorigenic cell phenotypes
dc.typeJournal Article
dspace.entity.typePublication
local.contributor.authorid0000-0001-5035-4905
local.contributor.authorid0000-0002-3366-145X
local.contributor.authorid0000-0002-6525-3602
local.contributor.kuauthorSur, İlknur Erdem
local.contributor.kuauthorDeğirmenci, Nareg Pınarbaşı
local.contributor.kuauthorAksu, Ali Cenk

Files